Blenrep is still on sale in some ex-US markets, but brought in just $45 million last year, a fraction of GSK's projections of ...

The FDA has said it will create a rare disease innovation hub to help speed the development of new treatments and build ...

Burlington, Massachusetts-based Cardurion led the quartet with a $260 million Series B for its heart-focused drug pipeline, ...

Ursula von der Leyen has been re-elected as president of the European Commission following a secret ballot in the European ...

In the rapidly evolving field of inflammasome therapeutics, the need for innovative approaches to overcome the preclinical ...

During the pharma group's first-half results update, Jennifer Taubert, chair of J&J's worldwide innovation group, said that ...

When it comes to life sciences manufacturing, there's nothing quite so daunting as a tech transfer - moving a product from ...

Boehringer Ingelheim has joined forces with digital health firm Brainomix on a project to improve the care of people with ...

Gilead Sciences' chief medical officer, Merdad Parsey, will leave the company in early 2025, becoming the latest in a series ...

The hearing – scheduled for 23rd July – is part of an ongoing investigation by the committee into PBMs' alleged ...

The House Committee on Oversight and Accountability will quiz leaders of pharmacy benefit managers (PBMs) at a hearing next ...